Reaction
Expanded Disability Status Scale Score Increased reporting signals
As of the last recalculation, Expanded Disability Status Scale Score Increased appears in 1,229 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is FINGOLIMOD HCL (PRR 289.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fingolimod Hcl | 672 | 289.1 | 291.4 |
| Siponimod | 77 | 155.9 | 157.2 |
| Ofatumumab | 112 | 62.7 | 62.9 |
| Cladribine | 16 | 28.6 | 28.6 |
| Ocrelizumab | 93 | 27.4 | 27.4 |
| Alemtuzumab | 25 | 22.3 | 22.4 |
| Teriflunomide | 52 | 20.3 | 20.3 |
| Glatiramer Acetate | 62 | 18.5 | 18.5 |
| Amantadine | 8 | 8.8 | 8.8 |
| Interferon Beta-1B | 9 | 8.0 | 8.0 |
| Dalfampridine | 21 | 5.0 | 5.0 |
| Dimethyl Fumarate | 34 | 4.8 | 4.8 |
| Natalizumab | 44 | 4.2 | 4.2 |